Literature DB >> 27447837

Continuous precipitation of process related impurities from clarified cell culture supernatant using a novel coiled flow inversion reactor (CFIR).

Nikhil Kateja1, Harshit Agarwal1, Aditya Saraswat1, Manish Bhat1, Anurag S Rathore2.   

Abstract

Coiled Flow Inverter Reactor (CFIR) has recently been explored for facilitating continuous operation of several unit operations involved in downstream processing of biopharmaceuticals such as viral inactivation and protein refolding. The application of CFIR for continuous precipitation of clarified cell culture supernatant has been explored. The pH based precipitation is optimized in the batch mode and then in the continuous mode in CFIR using a design of experiments (DOE) study. Improved clearance of host cell DNA (52× vs. 39× in batch), improved clearance of host cell proteins (HCP) (7× vs. 6× in batch) and comparable recovery (90 vs. 91.5 % in batch) are observed along with six times higher productivity. To further demonstrate wider applicability of CFIR in performing continuous precipitation, two more case studies involving use of two different precipitation protocols (CaCl2 based and caprylic acid based) are also performed. In both cases, clearance of host cell DNA, HCP, and product recovery are found to be comparable or better in CFIR than in batch operations. Moreover, increase in productivity of 16 times (CaCl2 based) and eight times (caprylic acid based) is obtained for the two precipitation protocols, respectively. The data clearly demonstrate that CFIR can be seamlessly integrated into a continuous bioprocess train for performing continuous precipitation of clarified cell culture supernatant. To our knowledge this is the first report of such use.
Copyright © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Antibody Production; Coiled flow inversion reactor; Continuous precipitation; Continuous processing; Protein A chromatography

Mesh:

Substances:

Year:  2016        PMID: 27447837     DOI: 10.1002/biot.201600271

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  7 in total

Review 1.  Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development.

Authors:  Nagesh K Tripathi; Ambuj Shrivastava
Journal:  Front Bioeng Biotechnol       Date:  2019-12-20

2.  Automation of Dead End Filtration: An Enabler for Continuous Processing of Biotherapeutics.

Authors:  Garima Thakur; Vishwanath Hebbi; Subhash Parida; Anurag S Rathore
Journal:  Front Bioeng Biotechnol       Date:  2020-07-03

3.  Continuous integrated antibody precipitation with two-stage tangential flow microfiltration enables constant mass flow.

Authors:  Daniel Burgstaller; Alois Jungbauer; Peter Satzer
Journal:  Biotechnol Bioeng       Date:  2019-01-23       Impact factor: 4.530

Review 4.  Developments and opportunities in continuous biopharmaceutical manufacturing.

Authors:  Ohnmar Khanal; Abraham M Lenhoff
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

5.  An integrated and continuous downstream process for microbial virus-like particle vaccine biomanufacture.

Authors:  Lukas Gerstweiler; Jagan Billakanti; Jingxiu Bi; Anton P J Middelberg
Journal:  Biotechnol Bioeng       Date:  2022-05-10       Impact factor: 4.395

6.  Effect of a storytelling intervention on the retention of serodiscordant couples in ART/PrEP services at antenatal clinic in Namacurra province in Zambézia, Mozambique.

Authors:  Carolyn M Audet; Erin Graves; Almiro M Emílio; Ariano Matino; Paula Paulo; Arifo M Aboobacar; Carlota L Fonseca; Sara Van Rompaey; Caroline De Schacht
Journal:  Contemp Clin Trials Commun       Date:  2021-05-06

7.  Continuous cell flocculation for recombinant antibody harvesting.

Authors:  Daniel Burgstaller; Walpurga Krepper; Josselyn Haas; Marine Maszelin; Jure Mohoric; Katja Pajnic; Alois Jungbauer; Peter Satzer
Journal:  J Chem Technol Biotechnol       Date:  2017-12-08       Impact factor: 3.174

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.